Marvel Biosciences Corp. (TSXV:MRVL)
Canada · Delayed Price · Currency is CAD 0.1450
0.00 (0.00%)
Sep 18, 2026, 9:30 AM EST
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 9.14 million as of September 18, 2026. Its market cap has decreased by -32.19% in one year.
Market Cap
9.14M
Enterprise Value
10.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
ChartMarket Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 9.14M, a decrease of -28.09%. That is a compound annual growth rate of -6.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 9.14M | 16.71% |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hemostemix | 15.86M |
| Rapid Dose Therapeutics | 14.33M |
| PreveCeutical Medical | 12.76M |
| Britannia Life Sciences | 11.52M |
| Rakovina Therapeutics | 10.92M |
| Glow Lifetech | 7.70M |
| Kane Biotech | 6.15M |
| MYND Life Sciences | 5.22M |